2023
Cost-effectiveness of chimeric antigen receptor T-cell therapy in adults with relapsed or refractory follicular lymphoma
Potnis K, Di M, Isufi I, Gowda L, Seropian S, Foss F, Forman H, Huntington S. Cost-effectiveness of chimeric antigen receptor T-cell therapy in adults with relapsed or refractory follicular lymphoma. Blood Advances 2023, 7: 801-810. PMID: 36342852, PMCID: PMC10011202, DOI: 10.1182/bloodadvances.2022008097.Peer-Reviewed Original ResearchConceptsCAR T-cell therapyT-cell therapyQuality-adjusted life yearsIncremental cost-effectiveness ratioCAR T cellsChimeric antigen receptor T-cell therapySOC therapyFollicular lymphomaT cellsLife yearsR FLRefractory follicular lymphomaT cell strategiesThird-line settingLines of therapyIncremental clinical benefitUS payer perspectiveCost-effectiveness ratioTherapy remissionUnselected patientsCare therapyClinical benefitClinical trialsTreatment strategiesPayer perspective
2022
A systematic review of cost-effectiveness analyses on endovascular thrombectomy in ischemic stroke patients
Wu X, Khunte M, Gandhi D, Sanelli P, Forman HP, Malhotra A. A systematic review of cost-effectiveness analyses on endovascular thrombectomy in ischemic stroke patients. European Radiology 2022, 32: 3757-3766. PMID: 35301558, DOI: 10.1007/s00330-022-08671-0.Peer-Reviewed Original ResearchConceptsQuality-adjusted life yearsCost-effectiveness analysisConsolidated Health Economic Evaluation Reporting Standards (CHEERS) checklistSocietal perspectiveLife yearsIndirect costsFuture cost-effectiveness analysesLong-term horizonPay thresholdsShort-term perspectiveQALY scoresEffectiveness analysisStandard checklistCostWillingness
2014
Cost-Effectiveness of Angiographic Imaging in Isolated Perimesencephalic Subarachnoid Hemorrhage
Kalra VB, Wu X, Forman HP, Malhotra A. Cost-Effectiveness of Angiographic Imaging in Isolated Perimesencephalic Subarachnoid Hemorrhage. Stroke 2014, 45: 3576-3582. PMID: 25336513, DOI: 10.1161/strokeaha.114.006679.Peer-Reviewed Original ResearchConceptsOptimal strategyNet monetary benefitCost-effectiveness analysisComprehensive cost-effectiveness analysisCost-effective strategyBase case scenarioDistributional variablesMonetary benefitsLife yearsWillingnessBase caseSensitivity analysisMonte Carlo simulationsInitial CTAPayCarlo simulationsPart of followCostStrategiesVariablesBenefitsDecision treeCase scenarioPurpose
1995
Evaluating health services: the importance of patients' preferences and quality of life.
Yin D, Forman H, Langlotz C. Evaluating health services: the importance of patients' preferences and quality of life. American Journal Of Roentgenology 1995, 165: 1323-8. PMID: 7484556, DOI: 10.2214/ajr.165.6.7484556.Peer-Reviewed Original ResearchConceptsQuality-adjusted life yearsQuality of lifeHealth statesCost-effectiveness of medical proceduresHealth-related quality of lifePatient preferencesHealth-related qualityHealth care programsQuality-adjusted life years methodMeasure patient preferencesHealth care dollarsMedical proceduresHealth programsHealth servicesCare programCost-effectiveness analysisHealth insuranceLife yearsOutcomes researchPatient outcomesHealthTechnology assessmentClinical researchMonetary valueDollar amount